Design, power, and interpretation of studies in the standard murine model of ALS

Scott, Sean, Kranz, Janice E., Cole, Jeff, Lincecum, John M., Thompson, Kenneth, Kelly, Nancy, Bostrom, Alan, Theodoss, Jill +4 more·2008·Amyotrophic Lateral Sclerosis
DOI 10.1080/17482960701856300

Cited by (503)

Items 301–400 of 503

  1. Between two stools: preclinical research, reproducibility, and statistical design of experiments
    Penny S. Reynolds · 2022 · BMC Research Notes
  2. Stem cell therapy in spinal trauma: Does it have scientific validity?
    Harvinder Singh Chhabra, Kanchan Sarda · 2014 · Indian Journal of Orthopaedics
  3. Issues in the design, analysis, and application of rodent developmental neurotoxicology studies
    Charles V. Vorhees, Michael T. Williams · 2021 · Neurotoxicology and Teratology
  4. Motoneuron excitability dysfunction in ALS: Pseudo‐mystery or authentic conundrum?
    Sherif M. Elbasiouny · 2022 · The Journal of Physiology
  5. Progress in Therapy Development for Amyotrophic Lateral Sclerosis
    Kalina Venkova-Hristova, Alexandar Christov, Zarine Kamaluddin, Peter J. Kobalka, Kenneth Hensley · 2012 · Neurology Research International
  6. From Reproducibility to Translation in Neurodegenerative Disease.
    C. Zeiss · 2017 · ILAR journal
  7. Nonclinical data supporting orphan medicinal product designations: lessons from rare neurological conditions
    Maria Elzbieta Sheean, Violeta V. Stoyanova-Beninska, Giuseppe Capovilla, Dinah M. Duarte, Matthias P. Hofer, Michel Hoffmann, Armando Magrelli, Segundo Mariz, Stelios Tsigkos, Evyenia Shaili et al. · 2017 · Drug Discovery Today
  8. Intramuscular transplantation of bone marrow cells prolongs the lifespan of SOD1G93A mice and modulates expression of prognosis biomarkers of the disease
    Amaya Rando, Diego Pastor, Mari Carmen Viso-León, Anna Martínez‐Muriana, Raquel Manzano, Xavier Navarro, Rosario Osta, Salvador Martı́nez · 2018 · Stem Cell Research & Therapy
  9. Towards an artificial human lung: modelling organ-like complexity to aid mechanistic understanding
    María Victoria Humbert, Cosma Mirella Spalluto, Joseph Bell, Cornelia Blume, Franco Conforti, Elizabeth R. Davies, Lareb S. N. Dean, Paul T. Elkington, Hans Michael Haitchi, Claire L. Jackson et al. · 2022 · European Respiratory Journal
  10. Amyotrophic Lateral Sclerosis
    Nazem Atassi, David Schoenfeld, Merit Cudkowicz · 2012 · Cambridge University Press eBooks
  11. Potential new complication in drug therapy development for amyotrophic lateral sclerosis
    Svitlana N. Garbuzova-Davis, Avery Thomson, Crupa Kurien, R. Douglas Shytle, Paul R. Sanberg · 2016 · Expert Review of Neurotherapeutics
  12. From mice to mind: Strategies and progress in translating neuroregeneration
    Terry C. Burns, Catherine M. Verfaillie · 2015 · European Journal of Pharmacology
  13. The motor neuron m6A repertoire governs neuronal homeostasis and FTO inhibition mitigates ALS symptom manifestation
    Ya-Ping Yen, Ting-Hsiang Lung, Ee Shan Liau, Chuan‐Che Wu, Guanlin Huang, Fang-Yu Hsu, Mien Chang, Zheng-Dao Yang, Chia-Yi Huang, Zhong Zheng et al. · 2025 · Nature Communications
  14. Preclinical trials in Alzheimer’s disease: Sample size and effect size for behavioural and neuropathological outcomes in 5xFAD mice
    Mahvish Faisal, Jana Aid, Nodirov Bekzod Holiqjon o‘g‘li, Benjamin Lee, Miriam Ann Hickey · 2023 · PLoS ONE
  15. Identification of Human Monoclonal Antibodies Specific for Human SOD1 Recognizing Distinct Epitopes and Forms of SOD1
    Teresa J. Broering, Hongyan Wang, Naomi K. Boatright, Yang Wang, Katherine Baptista, Gilda Shayan, Kerry A. Garrity, Can Kayatekin, Daryl A. Bosco, C. Robert Matthews et al. · 2013 · PLoS ONE
  16. Teaching Experimental Design
    Derek Fry · 2014 · ILAR Journal
  17. Reducing suffering in experimental autoimmune encephalomyelitis (EAE)
    Wolfensohn, Sarah, Hawkins, Penny, Lilley, Elliot, Anthony, Daniel, Chambers, Charles, Lane, Sarah, Lawton, Martin, Voipio, Hanna-Marja, Woodhall, Gavin · 2013 · Journal of Pharmacological and Toxicological Methods
  18. Acidotoxicity and acid-sensing ion channels contribute to motoneuron degeneration
    Á T Behan, Bridget A. Breen, Marion C. Hogg, Ina Woods, Karen S. Coughlan, Mollie R. Mitchem, Jochen H.M. Prehn · 2013 · Cell Death and Differentiation · Retracted
  19. Characterisation of the pathogenic effects of the in vivo expression of an ALS-linked mutation in D-amino acid oxidase: Phenotype and loss of spinal cord motor neurons
    Nazanin Rahmani Kondori, Praveen Paul, Jacqueline P. Robbins, Ke Liu, John C. W. Hildyard, Dominic J. Wells, Jacqueline de Belleroche · 2017 · PLoS ONE
  20. Replication – why we need to publish our findings
    Michael J. Curtis, Darrell R. Abernethy · 2015 · Pharmacology Research & Perspectives
  21. Activity-dependent degeneration of axotomized neuromuscular synapses in WldS mice
    Rosalind Brown, Antony M. Hynes-Allen, Amanda Swan, Kosala N. Dissanayake, Thomas Henry Gillingwater, Richard R. Ribchester · 2015 · Neuroscience
  22. Focal and dose-dependent neuroprotection in ALS mice following AAV2-neurturin delivery
    Sarah K. Gross, Bo Sung Shim, Raymond T. Bartus, Dan Deaver, Zachary T. McEachin, Alexandre Bétourné, Nicholas M. Boulis, Nicholas John Maragakis · 2019 · Experimental Neurology
  23. Pathway identification through transcriptome analysis
    Takeshi Terabayashi, Gregory George Germino, Luís F. Menezes · 2020 · Cellular Signalling
  24. Effects of RAGE inhibition on the progression of the disease in hSOD1<sup>G93A</sup> ALS mice
    Liu, Liping, Killoy, Kelby M., Vargas, Marcelo R., Yamamoto, Yasuhiko, Pehar, Mariana · 2020 · Pharmacology Research &amp; Perspectives
  25. AAV-NRIP gene therapy ameliorates motor neuron degeneration and muscle atrophy in ALS model mice
    Chen, Hsin-Hsiung, Yeo, Hsin-Tung, Huang, Yun-Hsin, Tsai, Li-Kai, Lai, Hsing-Jung, Tsao, Yeou-Ping, Chen, Show-Li · 2024 · Skeletal Muscle
  26. Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis
    Sagit Golko-Perez, Silvia A. Mandel, Tamar Amit, Lana Kupershmidt, Moussa B. H. Youdim, Orly Weinreb · 2015 · Neurotoxicity Research
  27. NU-9 improves health of hSOD1G93A mouse upper motor neurons in vitro, especially in combination with riluzole or edaravone
    Barış Genç, Mukesh Gautam, Benjamin Helmold, Nuran Koçak, Aksu Günay, Gashaw M. Goshu, Richard B. Silverman, P. Hande Özdi̇nler · 2022 · Scientific Reports
  28. Pitfalls in the Quest of Neuroprotectants for the Perinatal Brain
    Pierre Gressèns, Virginia Le Verche, Mhoyra Fraser, Catherine I. Rousset, Leslie Schwendimann, Laura Bennet, Sherly A. George, Xiaoyang Wang, Carina E. Mallard, Barbara C. Tilley et al. · 2011 · Developmental Neuroscience
  29. Estimating the replicability of Brazilian biomedical science
    The Brazilian Reproducibility Initiative, Amaral, Olavo Bohrer, Carneiro, Clarissa França Dias, Neves, Kleber, Sampaio, Ana Paula Wasilewska, Gomes, Bruna Valério, Abreu, Mariana Boechat de, Tan, Pedro Batista, Mota, Gabriel Paz Souza, Goulart, Ricardo Netto et al. · 2025 · bioRxiv
  30. How clinical trials of myasthenia gravis can inform pre-clinical drug development
    Anna Rostedt Punga, Henry J. Kaminski, David P. Richman, Michael G Benatar · 2015 · Experimental Neurology
  31. The role of the IACUC in ensuring research reproducibility
    Jerald Silverman, James D Macy, Patricia A. Preisig · 2017 · Lab Animal
  32. Litter effects: Comments on Golub and Sobin's “Statistical modeling of litter as a random effect in mixed models to manage “intralitter likeness””
    Charles V. Vorhees, Michael T. Williams · 2019 · Neurotoxicology and Teratology
  33. Characterization and changes in neurotrophin receptor p75‐expressing motor neurons in SOD1 G93A G1H mice
    Kevin S. Smith, Robert Archer Rush, Mary‐Louise Rogers · 2015 · The Journal of Comparative Neurology
  34. Statistical Rigor and the Perils of Chance
    Katherine Susan Button · 2016 · eNeuro
  35. Menagerie: A text-mining tool to support animal-human translation in neurodegeneration research
    C. Zeiss, Dongwook Shin, B. Vander Wyk, Amanda P. Beck, Natalie Zatz, C. Sneiderman, H. Kilicoglu · 2019 · PLoS ONE
  36. α CAR IGF ‐1 vector targeting of motor neurons ameliorates disease progression in ALS mice
    Ioanna Eleftheriadou, Ioannis Manolaras, Elaine E. Irvine, Michael Dieringer, Antonio Trabalza, Nicholas D. Mazarakis · 2016 · Annals of Clinical and Translational Neurology
  37. Synergistic Effects of Riluzole and Sodium Butyrate on Barrier Function and Disease Progression of Amyotrophic Lateral Sclerosis Through the Gut‐Neuron Axis
    Yongguo Zhang, KaReisha Robinson, Yinglin Xia, Jun Sun · 2025 · Comprehensive physiology
  38. Increased motor neuron resilience by small molecule compounds that regulate IGF-II expression
    Teresia M. Osborn, Jonathan A. Beagan, Ole Isacson A · 2017 · Neurobiology of Disease
  39. Oxaloacetate treatment preserves motor function in SOD1G93A mice and normalizes select neuroinflammation-related parameters in the spinal cord
    Sudheer K. Tungtur, Heather Wilkins, Robert S. Rogers, Yomna Badawi, Jessica M. Sage, Abdulbaki Aǵbaş, Omar Jawdat, Richard J. Barohn, Russell Howard Swerdlow, Hiroshi Nishimune · 2021 · Scientific Reports
  40. Animal and cellular models of human disease
    Mark Johan Arends, Eric S. White, Bruce Whitelaw · 2015 · The Journal of Pathology
  41. Ethics of Animal Research
    I. Anna S. Olsson, Paul Robinson, Peter Sandøe · 2010 · CRC Press eBooks
  42. IL-10 based immunomodulation initiated at birth extends lifespan in a familial mouse model of amyotrophic lateral sclerosis
    Michael R. Strickland, Kristen R. Ibanez, Mariya Yaroshenko, Carolina Ceballos‐Diaz, David Borchelt, Paramita Chakrabarty · 2020 · Scientific Reports
  43. Optimizing Mouse Models of Neurodegenerative Disorders: Are Therapeutics In Sight?
    Cathleen M. Lutz, Melissa A. Osborne · 2013 · Future Neurology
  44. Non-Methylation-Linked Mechanism of REST-Induced Neuroglobin Expression Impacts Mitochondrial Phenotypes in a Mouse Model of Amyotrophic Lateral Sclerosis
    Zoë P. Van Acker, Ken Declerck, Evi Luyckx, Wim Vanden Berghe, Sylvia Dewilde · 2019 · Neuroscience
  45. New forms of checks and balances are needed to improve research integrity
    Elizabeth J. Iorns, Christin Chong · 2014 · F1000Research
  46. Presymptomatically applied AMPA receptor antagonist prevents calcium increase in vulnerable type of motor axon terminals of mice modeling amyotrophic lateral sclerosis
    Roland Patai, Melinda Paizs, Massimo Tortarolo, Caterina Bendotti, Izabella Obál, József I. Engelhardt, László Siklós · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  47. New animal models of progressive neurodegeneration: tools for identifying targets in predictive diagnostics and presymptomatic treatment
    R. Andrew Tasker, Amber L. Marriott, Christopher A. Shaw · 2010 · The EPMA Journal
  48. [Minocycline for the treatment of amyotrophic lateral sclerosis: neuroprotector or neurotoxin? Reflections on another failure of translational medicine].
    Josep Gámez · 2008 · PubMed
  49. Dose-Dependent Effects of Binge-Like Methamphetamine Dosing on Dopamine and Neurotrophin Levels in Rat Brain
    Andréia Moreira da Silva Santos, John P. Kelly, Karen Doyle · 2017 · Neuropsychobiology
  50. Ok Google, how could I design therapeutics against prion diseases?
    Marta Rigoli, Giovanni Spagnolli, Pietro Faccioli, Jesús R. Requena, Emiliano Biasini · 2019 · Current Opinion in Pharmacology
  51. Two years into the Brazilian Reproducibility Initiative: reflections on conducting a large-scale replication of Brazilian biomedical science
    Kleber Neves, Clarissa F. D. Carneiro, Ana Paula Wasilewska‐Sampaio, Mariana Boechat de Abreu, Bruna Valério‐Gomes, Pedro Batista Tan, Olavo B. Amaral · 2020 · Memórias do Instituto Oswaldo Cruz
  52. Neuroimaging findings in preclinical amyotrophic lateral sclerosis models—How well do they mimic the clinical phenotype? A systematic review
    Amelia Elaine Cannon, Wolfgang Emanuel Zürrer, Charlotte Zejlon, Zsolt Kulcsár, Sebastian A. Lewandowski, Fredrik Piehl, Tobias Granberg, Benjamin Victor Ineichen · 2023 · Frontiers in Veterinary Science
  53. 5-Hydroxytryptamine: a potential therapeutic target in amyotrophic lateral sclerosis
    Shi-Shi Jiang, Meng-Ni Gong, Wei Rao, Wen Chai, Wenzhi Chen, Xiong Zhang, Hongbing Nie, Renshi Xu · 2023 · Neural Regeneration Research
  54. Contribution of the Breadth and Depth of IACUC Membership to Experimental Design as a Factor in Research Reproducibility.
    Swapna Mohan, Robert Wayne Barbee, Susan Brust Silk · 2018 · Europe PMC (PubMed Central)
  55. Oxymatrine Extends Survival by Attenuating Neuroinflammation in a Mouse Model of Amyotrophic Lateral Sclerosis
    Jian Zhang, Dongxiao Li, Guofeng Yang, Xiangjian Zhang, Lin Chen, Yingzhen N. Zhang, Xiaoming Qi, Yi Li, Yansu Guo · 2021 · Neuroscience
  56. Logical Experimental Design and Execution in the Biomedical Sciences
    Daniel Holder, Michael J. Marino · 2017 · Current Protocols in Pharmacology
  57. Porcine pancreatic ductal epithelial cells transformed with KRASG12D and SV40T are tumorigenic
    Katie L. Bailey, Sara Cartwright, Neesha S. Patel, Neeley A. Remmers, Audrey J. Lazenby, Michael Anthony Hollingsworth, Mark A. Carlson · 2021 · Scientific Reports
  58. Lithium time-to-event trial in amyotrophic lateral sclerosis stops early for futility
    Michael Swash · 2010 · The Lancet Neurology
  59. Should clinicians care about preclinical animal research?
    Shai D. Silberberg · 2013 · Neurology
  60. Interview with James Heywood
    James Heywood · 2011 · Rejuvenation Research
  61. Safety and efficacy evaluation of intracerebroventricular human neural stem cell transplantation in SOD1 mice as a novel approach for ALS
    Ivan Lombardi, Clelia Ferrero, Edvige Vulcano, Daniela Maria Rasà, Maurizio Gelati, Diego Pastor, Rose Mary Carletti, Silvia de la Morena, Daniela Celeste Profico, Sabrina Longobardi et al. · 2025 · Journal of Translational Medicine
  62. Human CAR Tregs Targeting SOD1 and Expressing BDNF Reduce Inflammation and Delay Disease in G93A hSOD1-NSG Mice
    David J. Graber, W. James Cook, Marie-Louise Sentman, Joana M. Murad-Mabaera, Elijah W. Stommel, Charles L. Sentman · 2025 · Cells
  63. Improving the predictive power of mouse models
    Martín F. Pera, Andy Greene, Lon R. Cardon, Gregory W. Carter, Elissa J. Chesler, Gary A. Churchill, Vivek Kumar, Cathleen M. Lutz, Steven C. Munger, Stephen A. Murray et al. · 2024 · Nature Biotechnology
  64. Differential involvement of vesicular and glial glutamate transporters around spinal α-motoneurons in the pathogenesis of SOD1G93A mouse model of amyotrophic lateral sclerosis
    Tomohiro Ohgomori, Ryo Yamasaki, Hideyuki Takeuchi, Kenji Kadomatsu, Jun‐ichi Kira, Shozo Jinno · 2017 · Neuroscience
  65. Advice on statistical analysis, and new journal guidance for experimental design and analysis
    Michael J. Curtis, Darrell R. Abernethy · 2014 · Pharmacology Research & Perspectives
  66. Improving translational studies: lessons from rare neuromuscular diseases
    Dominic J. Wells · 2015 · Disease Models & Mechanisms
  67. Embryonic motor neuron programming factors reactivate immature gene expression and suppress ALS pathologies in postnatal motor neurons
    Emily R. Lowry, Tulsi Patel, Jonathon A. Costa, Elizabeth Chang, Shahroz Tariq, Hranush Melikyan, Ian J. Davis, Siaresh Aziz, Georgia Ntermentzaki, Francesco Lotti et al. · 2025 · Nature Neuroscience
  68. Current status and new avenues of stem cell-based preclinical and therapeutic approaches in amyotrophic lateral sclerosis
    Letizia Mazzini, Fabiola De Marchi, Leonora Bużańska, Antonia Follenzi, Joel Clinton Glover, Maurizio Gelati, Ivan Lombardi, Margherita Maioli, Fátima Mesa-Herrera, Dinko Mitrečić et al. · 2024 · Expert Opinion on Biological Therapy
  69. Two decades testing interventions in transgenic mouse models of Alzheimer's disease: designing and interpreting studies for clinical trial success
    Kieren J. Egan, Malcolm Robert Macleod · 2014 · Clinical Investigation
  70. Expectations for the Methodology and Translation of Animal Research: A Survey of the General Public, Medical Students and Animal Researchers in North America
    Ari Robin Joffe, Meredith Bara, Natalie R. Anton, Nathan Nobis · 2016 · Alternatives to Laboratory Animals
  71. A designer chaperone against prion diseases
    Emiliano Biasini · 2019 · Nature Biomedical Engineering
  72. Methodological standards, quality of reporting and regulatory compliance in animal research on amyotrophic lateral sclerosis: a systematic review
    Joana Guilherme-Fernandes, Nuno Henrique Franco, Andrew J. Grierson, Jan Hultgren, Andrew J. Furley, I. Anna S. Olsson · 2019 · BMJ Open Science
  73. Amyotrophic Lateral Sclerosis
    David S., J. Ashley, D. Elizabeth, J. Jefferson P. Perry · 2011 · InTech eBooks
  74. Adding more muscle and nerve to clinical trials
    ROBIN A. CONWIT, Minal J. Bhanushali, John D. Porter, Petra Kaufmann, Laurie Gutmann · 2011 · Muscle & Nerve
  75. Reproducibility in Biomedical Research
    Kevin Mullane, Michael J. Curtis, Michael J. Williams · 2017 · Elsevier eBooks
  76. The '3Is' of animal experimentation
    2012 · Nature Genetics
  77. Neuroinflammation and Oxidative Stress in SOD1 Animal Models of ALS: A Meta-analysis Study of Their Effects on Disease Onset and Progression
    Maria Ciuro, Maria Sangiorgio, Giampiero Leanza, Rosario Gulino · 2026 · Molecular Neurobiology
  78. TwinF interface inhibitor FP802 prevents retinal ganglion cell loss in a mouse model of amyotrophic lateral sclerosis
    Yumeng Wang, Jing Yan, Sarah K. Williams, Richard Fairless, Hilmar Bading · 2024 · Acta Neuropathologica Communications
  79. Expectations for methodology and translation of animal research: a survey of health care workers
    Ari Robin Joffe, Meredith Bara, Natalie R. Anton, Nathan Nobis · 2015 · BMC Medical Ethics
  80. Some Salt with Your Statin, Professor?
    Malcolm Robert Macleod · 2014 · PLoS Biology
  81. Transplanted Human Bone Marrow Endothelial Progenitor Cells Prolong Functional Benefits and Extend Survival of ALS Mice Likely via Blood-Spinal Cord Barrier Repair
    Svitlana N. Garbuzova-Davis, Cesar V. Borlongan · 2023 · Stem Cell Reviews and Reports
  82. Copper in Brain and Neurodegeneration
    Jeffrey R. Liddell, Ashley Ian Bush, Anthony Robert White · 2004 · Encyclopedia of Inorganic and Bioinorganic Chemistry
  83. The murky path to drug discovery in ALS becomes clearer
    Paul H Gordon · 2013 · The Lancet Neurology
  84. References
    Christopher A. Shaw · 2017 · Wiley eBooks
  85. Better Utilization of Mouse Models of Neurodegenerative Diseases in Preclinical Studies: From the Bench to the Clinic
    Christopher Janus, Carolina Hernandez, Victoria deLelys, Hanno M. Roder, Hans Welzl · 2016 · Methods in molecular biology
  86. Methodological rigour in preclinical urology: a systematic review reporting research quality over a 14‐year period
    Seung Hyun Park, Se Bee Lee, Seoyeon Park, Eun Young Kim, Damiano Pizzol, Mike Trott, Yvonne Barnett, Ai Koyanagi, Louis Jacob, Pınar Soysal et al. · 2023 · British Journal of Urology
  87. A polytherapy approach demonstrates therapeutic efficacy for the treatment of SOD1 associated amyotrophic lateral sclerosis
    Jeremy Stephen Lum, Mikayla L. Brown, Natalie E. Farrawell, Rachael Bartlett, Christen G. Chisholm, Jody Gorman, Anthony Dosseto, Florian W. Dux, Lachlan E. McInnes, Heath W. Ecroyd et al. · 2025 · EBioMedicine
  88. Why is ALS so Difficult to Treat?
    John Turnbull · 2014 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
  89. Animal Models and the Search for Drug Treatments for Traumatic Brain Injury
    P. Pound · 2020 · Advances in neuroethics
  90. Preclinical Milestones in MECP2 Gene Transfer for Treating Rett Syndrome
    Indumathy Jagadeeswaran, Jiyoung Oh, Sarah E. Sinnett · 2024 · Developmental Neuroscience
  91. Enhanced Interleukin 6 Trans-Signaling Modulates Disease Process in Amyotrophic Lateral Sclerosis Mouse Models
    Carol Milligan, Dale O. Cowley, William Stewart, Alyson M. Curry, M. Elizabeth Forbes, Brian M. Rector, Annette T. Hastie, Liang Liu, Gregory A. Hawkins · 2025 · Brain Sciences
  92. Disparity of outcomes: the limits of modeling amyotrophic lateral sclerosis in murine models and translating results clinically
    Pierre Zwiegers, Christopher A. Shaw · 2015 · Journal of Controversies in Biomedical Research
  93. Neurotrophic Therapy for ALS/MND
    Mary‐Louise Rogers · 2014 · Springer eBooks
  94. Future of Regulatory Safety Assessment
    Gerd Bode, Petra Starck-Lantova, Peter-Juergen Kramer · 2023 · Springer eBooks
  95. The 3Rs in zebrafish research
    Kamar E. Ameen‐Ali, Claire E. Allen · 2024 · CABI eBooks
  96. The Principles of Experimental Design and the Determination of Sample Size When Using Animal Models of Traumatic Brain Injury
    Michael F. W. Festing · 2018 · Neuromethods
  97. The influence of metallothionein treatment and treadmill running exercise on disease onset and survival in SOD1 G93A amyotrophic lateral sclerosis mice
    Katherine E. A. Lewis, William M. Bennett, Christopher Leigh Blizzard, Adrian K. West, Roger S. Chung, Meng Inn Chuah · 2020 · European Journal of Neuroscience
  98. Bad Science: Cause and Consequence
    Steve Elliott · 2016 · Journal of Pharmaceutical Sciences
  99. Diseases of Motor Neurons and Neuromuscular Junctions
    Harald W. Sontheimer · 2021 · Elsevier eBooks
  100. Amyotrofik Lateral Skleroz Patofizyolojisi ve Tedavi Yaklaşımları
    Zeynep YILDIRIM, Dicle Naz TOKTAŞ, Öznur DEMİR, Zülfiye Gül, Burcu Şen Utsukarçi · 2023 · Hacettepe University Journal of the Faculty of Pharmacy